Fact checked by Nick Blackmer Key Takeaways Foundayo is a newly approved GLP-1 weight loss pill that can be taken any time of ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Amazon will offer delivery of Eli Lilly's new weight-loss pill Foundayo and stock it at kiosks at some of the company's ...

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, constipation, or diarrhea.

Foundayo, a once-daily oral GLP-1 medication approved for obesity and weight-related issues, ranges in cost from $25 to $349 per month ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

Eli Lilly and Co. announced Thursday that its new weight-loss pill is now available in retail pharmacies in the United States ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...